+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pompe Disease Pipeline Drugs and Companies, 2021- Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials

  • PDF Icon

    Report

  • 70 Pages
  • November 2021
  • Region: Global
  • VPA Research
  • ID: 5463944
Pompe Disease pipeline drugs and companies, 2021- Phase, Mechanism of Action, Route, Licensing/collaboration, pre-clinical and clinical trials

The global comprehensive report on “Pompe Disease pipeline drugs and companies” presents key-decision makers with critical insights into Pompe Disease pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.

Pompe Disease pipeline Drug Snapshot, 2021


The Pompe Disease pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Pompe Disease. In addition to recent status, overview of drugs is included in the study. Wide range of Pompe Disease drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.

Pompe Disease drug development pipeline by phase


The Pompe Disease pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Pompe Disease pipeline candidates is provided in the report enables you to understand timetable developments in Pompe Disease therapeutic area.

Pompe Disease pipeline drug Technology, Licensing and Collaboration Details


Details of technologies used for development of Pompe Disease pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Pompe Disease research study. Companies looking to partner with other players are also detailed in the report.

Pompe Disease- mechanism of action of pipeline candidates


Pompe Disease pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Pompe Disease companies are identified to support decision makers target the most potential drugs under development.

Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Pompe Disease drug administration.

Pompe Disease Drugs- Preclinical and Clinical Trials


This chapter in Pompe Disease preclinical and clinical trials assists in gaining clear understanding of the timetable developments in Pompe Disease product area. Preclinical and clinical trial details of pipeline candidates for Pompe Disease are detailed in the report. Details including participants, duration, companies, locations and others are provided for the trials.

Pompe Disease companies and Profiles


Companies developing Pompe Disease pipeline products are analyzed in the industry report, presenting details of business overview, location, and year of establishment, contacts, key employees, and a brief business profile.

Pompe Disease Market Developments


The report presents the recent news and developments in the Pompe Disease pipeline industry. Progress of candidates, mergers, acquisitions, asset transactions, licensing, collaborations, partnership and joint ventures, regulatory approvals, marketing and other relevant news and deals are discussed in the report.

Reasons to Buy

  • Make better-informed decisions based on the current status of each of the pipeline drug candidate
  • Identify new business opportunities by evaluating the progress of the Pompe Disease R&D pipeline
  • Analyze the market and research segments based on a comprehensive analysis of Pompe Disease pipeline drugs and clinical trials
  • Identify Pompe Disease drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
  • Gain clear understanding of the Pompe Disease drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
  • Check the Pompe Disease pipeline progress of target companies and key strategies of leading players
  • Gain real-time insights into the global Pompe Disease pipeline news, developments and insights

Scope of the Report

  • Disease overview including Pompe Disease symptoms, widely used treatment options, companies and other details are included
  • Pompe Disease Pipeline Summary including the dominant phase type, number of drug candidates progressing to advanced phases, early stage pipeline candidates, leading companies, dominant route of mechanism and route of administration and other details are provided.
  • Pompe Disease pipeline drug count by phase, company and mechanism of action
  • Pompe Disease companies investing R&D resources in pipeline
  • Dominant Mechanism of Action
  • Most researched route of administration
  • For each pipeline candidate, drug, originator, co-developers, other companies, special status, phase, synonym, current status and other details are included
  • Clinical trial information for each Pompe Disease pipeline candidate are provided including preclinical, phase 1, phase 2 and phase 3 details
  • Pompe Disease companies including their business snapshot, business description and Pompe Disease pipelines are included.
  • Recent Pompe Disease market developments, pipeline news and deals are provided

Table of Contents

1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Executive Summary
2.1 Pompe Disease Disease overview
2.2 Companies investing in Pompe Disease industry
3 Pompe Disease Pipeline Snapshot, 2021
3.1 Pompe Disease Pipeline Drugs- Dominant phase type
3.2 Pompe Disease pipeline Drugs- Leading Mechanism of Action
3.3 Pompe Disease Pipeline Drugs- Widely researched Route of Administration
3.4 Pompe Disease Pipeline- New Molecular Entity
3.5 Pompe Disease pipeline- Companies, Universities and Institutes
4. Pompe Disease Drug Profiles
4.1 Current Status of Pompe Disease Drug Candidates, 2021
4.2 Pompe Disease Drugs in Development- Originator/Licensor
4.3 Pompe Disease Drugs in Development- Route of Administration
4.4 Pompe Disease Drugs in Development- New Molecular Entity (NME)
5. Pompe Disease Clinical Trials
5.1 Preclinical Trial details
5.2 Phase 1 Clinical Trial Details
5.3 Phase 2 Clinical Trial Details
5.4 Phase 3 Clinical Trial Details
6. Pompe Disease Companies and Universities
6.1 Leading Pompe Disease companies researching in drug development
6.2 Leading Pompe Disease Universities/Institutes investing in drug development
7. Pompe Disease News and Deals
7.1 Recent Pompe Disease Market Developments
7.2 Pipeline Drug News Updates
7.3 Pipeline Company updates
8. Appendix
8.1 Sources and Research Methodology
8.2 Online Database
8.3 Primary and Secondary Methodology
8.4 Customization options
8.5 Contact